Studies on clear cell renal cell cancer suggested that exhausted immune cells and the lack of PD-1, PD-L1, and CTLA-4 expressions could underline the non-responsiveness to immunotherapy (105). This evidence concerns the gene CTLA4 and clear cell renal carcinoma.